Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  Antibodies
  Mutations
  AlzGene
  Research Models
Resources
  Jobs
  Conference Calendar
  Grants
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Expert Opinion
  Ask the Expert
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Early-Onset Familial AD: Overview
Early-Onset Familial AD: A Historic Discovery


Posted 9 April 2007

 Read Previous Essay  |  View Index  |  Read Next Essay

How Early-onset Dementia Led to a Historic Discovery

When Alois Alzheimer described the case of Auguste D. to an audience of fellow psychiatrists in Tuebingen, Germany, in 1906, what set her case apart was the fact that her dementia appeared before she was 50 years old. Dementia at a more advanced age was considered part of normal aging. But this relatively young German hausfrau's increasingly disruptive behavior caused her distraught husband to bring her in for a doctor's examination when she was 51. It fell upon Dr. Alzheimer to follow her case. Alzheimer's mentor Emil Kraepelin of Munich, the foremost psychiatrist in his day, promoted the fundamental insight that dementia is a physical, organic disease of the brain, so when Auguste D. died, Alzheimer examined her brain for unusual pathology. At the time, based on the contemporary theories of Freud, psychotic or "crazy" behavior was thought to result from psychodynamic causes, so Alzheimer's discovery of plaques and tangles in Auguste D.'s brain was a landmark (although his contemporaries were underwhelmed). The German medical literature of the time recognized that this mid-life dementia was more common in certain families, so the idea of familial Alzheimer disease goes back to those days, as well.

Until recent times, the term Alzheimer disease referred exclusively to cases where the disease expressed itself before the age of 65. Alzheimer and Kraepelin themselves had defined the disease in this way. Indeed Alzheimer believed that in older people, dementia was the result of atherosclerosis. For decades thereafter, most investigators distinguished Alzheimer disease as a rare mid-life affliction from garden-variety senility. This distinction was blurred by the fact that even within a family, the disease would develop across a range of ages, from 50 to 70.

In the 1960s, Sir Martin Roth, Bernard Tomlinson, and Gary Blessed reported that the pathology of plaques and tangles also occurred across middle to old age. But it was not until the 1970s that the New York pathologist Robert Katzman asserted that late-onset AD was no different from early-onset AD. "The brilliant contribution Katzman made was that the general decline of cognition and life function, as well as the pathology, follow a similar pattern in late-onset, early-onset, and familial AD," notes neurologist Daniel Pollen at the University of Massachusetts Medical Center in Worcester.

Since then, scientists have come to agree that the distinction between "presenile" and "senile" forms of AD dementia is obsolete. The early-onset and late-onset forms are now seen as a single disease. Alzheimer disease became a major public health issue in an aging society, and its occurrence in elderly people is what people typically mean today when they speak of Alzheimer disease. Indeed, in an ironic twist, almost no one thinks of AD as a disease that a younger person can get. The original form of Alzheimer disease has been largely forgotten, except by some researchers.—Gabrielle Strobel.


Comments
Comment by:  Jean-François FONCIN
Submitted 9 April 2007 Posted 9 April 2007

A small correction: In 1906, Sigmund Freud's ideas about the psychogenesis of mental disease were far from being generally accepted. They were restricted to "neuroses" (hysteria and the like) as distinct from "psychoses". Kraepelin thought that not only dementia in the modern sense, but also what he called "Dementia praecox" (Bleuler's schizophrenia - the name stuck) was "a physical, organic disease of the brain". This was a major reason for Kraepelin to be enthusiastic over Alzheimer's discovery. Kraepelin believed that, after "middle age dementia" (which he called "Alzheimer's disease"), "early dementia" (which he would have liked to be called "Kraepelin's disease") would be elucidated through the same methods.

References:
BLEULER E. (1911) : Dementia praecox oder Gruppe der Schizophrenien. Leipzig u. Wien.

View all comments by Jean-François FONCIN
  Submit a Comment

 
Cast your vote and/or make a comment on this page. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

 
Print this page
Email this page
Alzforum News
Text size
Share & Bookmark
Efad/EOAD Sidebars

How Early-onset Dementia Led to a Historic Discovery

Pushing the Envelope on Early Diagnosis

The Specter of Suicide

Taking the Plunge into Genetic Testing

Prevention With Statins: Can the Brain Learn From the Heart?

Efad/EOAD Interviewss

A Diagnostic Odyssey
NPR Interviews with Thomas Debaggio
A Courageous Family
Interview with Jennifer Williamson
One Man's Forward Approach
A Spouse's Perspective on Clinical Trials for eFAD
Q&A with Richard Bozanich
Interview with Lisa Genova

Early Onset AD Related Links

Actionalz.org Blog
AD Under 65 Message Board
Alzheimer Europe
Carved in Sand Blog
The Tangled Neuron
Early-Onset Issues
MayoClinic

Copyright © 1996-2008 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad